Lu-177 information

[Blackpatch]

Australia's somewhat lax radiation regulatory regime has resulted in Australian PCa researchers having been working with Lu-177 for rather longer than many in the US. These activities have generated information that is both timely and accessible (we do actually speak english down here, even if with an accent...), and I thought some of this may ne of interest.

Peter Mac in Melbourne is Australia's premiere cancer research facility and I decided to support their PCa R&D after receiving eSRT treatment there in early 2019. As luck would have it, Peter Mac were looking for some Australian money to help anchor US funding for their Lu-177 work, so I pitched in. Fortunately, I've not yet needed Lu-177, but I've been very impressed with the results and patient communications material coming out of PROSTICS, the theranostics and imaging centre of excellence that Peter Mac has set up petermac.org/ProsTIC.

PROSTIC's website is a bit of a rabbit warren, but the following links may be of some interest:

Current and forthcoming clinical trials, including some early-stage and immunotherapy-related studies

petermac.org/research/ProsT...

Inspiring success story of what Lu-177 can sometimes achieve if luck is with you

afr.com/policy/health-and-e...

Lu-177 R&D directions and publications

petermac.org/research/ProsT...

I hope that this wealth of information can be of value to our international brethren.

[Spyder54]

Great Share Blackpatch. . Experience talks. Here in the US, we are clearly going up the learning curve. Much appreciated,

Mike

St Pete, FL

USA